Kidney Res Clin Pract.  2019 Sep;38(3):295-308. 10.23876/j.krcp.19.042.

Acute kidney injury in the patient with cancer

Affiliations
  • 1Division of Nephrology, University of Virginia Health System, Charlottesville, VA, USA. mhr9r@virginia.edu
  • 2Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA.

Abstract

Dramatic advances in the care of patients with cancer have led to significant improvement in outcomes and survival. However, renal manifestations of the underlying cancer as well as the effects of anti-neoplastic therapies leave patients with significant morbidity and chronic kidney disease risks. The most common renal manifestations associated with cancer include acute kidney injury (AKI) in the setting of multiple myeloma, tumor lysis syndrome, post-hematopoietic stem cell therapy, and AKI associated with chemotherapy. Knowledge of specific risk factors, modification of risk and careful attention to rapid AKI diagnosis are critical for improving outcomes.

Keyword

Acute kidney injury; Chemotherapy; Neoplasms; Oncology

MeSH Terms

Acute Kidney Injury*
Diagnosis
Drug Therapy
Humans
Multiple Myeloma
Renal Insufficiency, Chronic
Risk Factors
Stem Cells
Tumor Lysis Syndrome
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr